Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine

NCT01738074 is registered in ClinicalTrials.gov with Center for Disease Control and Prevention, Henan Province as lead sponsor.

NCT NCT01738074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01738074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine
Lead sponsor
Center for Disease Control and Prevention, Henan Province
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2012
Completion date
December 31, 2014
Enrollment
10,020 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

double-blind, placebo control design, randomized